Contact
 

Join the Enterprise and Partners for a Webinar on a New Tool to Help Optimize HIV Vaccine Research

The Enterprise held a webinar on the challenges facing researchers who want to advance their vaccine candidate from preclinical studies to a first-in-human trial. The webinar introduced a new interactive webtool designed to help researchers navigate the landscape of expertise necessary for such transition and to provide estimated timelines and costs. Click here to view the webinar.  To access the webtool and to learn more about the project, please visit: http://www.vaccineenterprise.org/Benchtoclinic.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account